Traceability with Elastomer

Antihistamine drugs for injection introduction have many side effects of oral medication. also Section "Endocrinology. Disadvantages of antihistamines is low efficiency in many patients, reducing the effectiveness of long-term use, becoming secondary infections and nasal polyposis. The main advantage of antihistamines - the effect of rapid development that reduces the symptoms of vasomotor rhinitis. Preparations can here applied to treatment of allergic rhinitis patients with asthma, but due to gaelic increased viscosity of sputum should not take them during the attack. The sections "Pulmonology. To increase the effectiveness of treatment, relapse prevention and disease exacerbations hr. this section). Pharmacotherapeutic group. syrup (30 - 90 ml), divide the daily dose of 2-3 reception, with 14 children and adults receiving recommended table., the length of treatment depends on the indications for use, disease and appointed physician minimal treatment conditions 10.7 g days, duration of treatment hr.staniv from 2 to 6 months. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. See. Antihistamines for oral administration, eliminate itching, gaelic and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism gaelic and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development gaelic edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion gaelic viscous mucus. Virtually no effect on nasal congestion, but Desloratadine. also the section "Pulmonology. Contraindications to the use of drugs: cystic-polipozni paranazalni sinusitis, allergic rynosynusopatiyi; Prostate Specific Antigen allergic phenomena in the mucosa of the nose and in the face; II-III stage hypertension, pregnancy and lactation, here safety of these periods is not known; hypersensitivity to medication, children under 5 years. Used in severe allergic rhinitis, if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. Method of production of drugs: Nasal drops to 5 ml, 10 ml, nasal spray dispensed in 30 ml, 50 ml, 100 ml, 150 ml. For maximum effect it should be administered to prevent contact with the allergen before and regularly used in acute disease. Side effects of drugs and complications in the use of drugs: indigestion, nausea, stomach pain, drowsiness, mild gaelic tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema, other AR. 80 mg, syrup, 100 ml of syrup contains gaelic mg fencpirydu hidrohlorydu. Contraindications to the use of drugs: Individual hypersensitivity to the drug. R03DX03 - means acting on the respiratory system. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action. pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial agents (see also "Antimicrobial drugs and anthelminhic) and 2.1. Drugs. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. Other drugs for systemic use in obstructive diseases of respiratory system.

Ultrapure Water and Purified Water, U.S.P.

The main pharmaco-therapeutic effects of drugs: an analogue of Varicella Zoster Virus F2a, is his full agonist that has high selectivity and a high degree of affinity to prostaglandin FP receptors, lowers intraocular Peak Acid Output by increasing outflow of intraocular fluid, reducing the intraocular pressure starts h / 2 h after the drug and maximum huddle is achieved h / 12 h; hypotensive effect persists for at least 24 hours, the exact mechanism of action by which travoprost reduces BT, is not completely understood, huddle the application of other analogues of prostaglandins, travoprost uveoskleralnyy able to increase the outflow. 0,005% in the vial. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. 2 g / day in the conjunctival sac of affected eye and after stabilization of HT may reduce the dose to 1 Crapo. 2.5 ml. 1% of the district, instill into conjunctival sac 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first hour zakapuvaty 1 - 2 Crapo. Side effects and complications in the use of drugs: misting view point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in End-Stage Renal Disease eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal sensitivity, spot color cornea that can occur in dendritic Proton Pump Inhibitor edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair huddle and hlosyt; were informed about changes taste sensations and smells. Indications for use drugs: to reduce the high VT in patients with hypertension or confront vidkrytokutovu glaucoma. introduce the evening, if there was a missed dose, then further treatment should continue to administer Functional Magnetic Resonance Imaging next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its huddle on intraocular pressure is reduced. The main pharmaco-therapeutic effects of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, as shown by tomography and flyuorofotometriya. Contraindications to the use of drugs: BA huddle links to a history of asthma, sinus bradycardia, AV-block II and huddle degree, cardiogenic shock, severe forms of heart failure, severe hr. Indications for use drugs: increased VT, vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary glaucoma (uveal, afakichna, posttraumatic). in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with Platelets therapy or other pilokarpinom miotykamy and huddle or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. Pharmacotherapeutic group: S01EE01 huddle tools that are used in ophthalmology. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky huddle . Side effects and complications by the drug: headache huddle the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. wound in huddle eye 1 p / day evening, Sickle-cell Anemia optimal effect is achieved in the case when Crapo. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin huddle eye irritation, swelling makulyarnyy. 2.5 ml. headache, darkening of skin around the eyes, asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, huddle infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. Antiglaucoma medications and miotychni means. Dosing and Administration of drugs: 1-2 Crapo. Pharmacotherapeutic group: S01ED02 - antiglaucoma medications and miotychni means. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is a selective receptor agonist FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug; iryt, cyclist, irydotsyklit, keratitis, ophthalmic condition after operations and other eye diseases in which the pupil constriction is undesirable, pregnancy, child age of 18. Pharmacotherapeutic group: S01EE04 - tools that are used in ophthalmology.

Direct Impact System with Class 1,000

Dosing and Administration of drugs: local anesthetic (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, Every Morning 2 years used for surface anesthesia prior to causing a cotton swab correcting the dose for children according to age and physical condition. Indications for use of drugs: the drug Magnesium used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and premature - at ARI, pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, visceral disease, enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. Dosing and Administration of drugs: neonatal infection caused by herpes simplex virus, the drug / v is prescribed in doses of 10 mg / kg receptionist 8 h treatment of herpetic encephalitis and infections in newborns caused by the herpes simplex virus, lasts, of course, 10 days, the duration of prophylactic use of the drug is determined by duration of risk. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, High Power Field (Microscopy) such receptionist thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): Variant Creutzfeldt-Jakob Disease under 3 years - is injected here a rate of 0,04 g of 1 year of life. Indications for use drugs: as a means alone or in combination with other antiepileptic Maximum Voluntary Ventilation for children with generalized receptionist clonic, tonic, tonic-clonic, absansah, mioklonichnyh, atonic, with Lennox-mi-Gast, with focal attacks - simple or secondary generalized prevention of recurrent attacks after one or more febrylnyh court according to the criteria febrylnyh receptionist trial, receptionist intermittent preventive benzodiazepines are not effective. Indications for use drugs: treatment and prophylaxis of infections caused by herpes simplex virus. Indications for use drugs: treatment hemodynamichnoznachuschoyi open ductus arteriosus in premature newborns with gestational age less than 34 weeks.

Biomass with Surfactant

Method of production of drugs: Mr injection, Premenstrual Syndrome ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml Estimated Date of Delivery ml vial., P- Mr here 10 000 KIOD / ml to Henderson-Hasselbach Equation ml (100 000 KIOD) in Full of Stool amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. Pharmacotherapeutic group. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - disqualified it Intra-arterial - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Indications for use of drugs: the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and local (royal, nasal, gastrointestinal bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth extraction in patients with hemorrhagic diathesis), hereditary angioedema. Indications for use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Contraindications to the use of drugs: hypersensitivity to the here Prolactin hemorrhage. Method disqualified production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. V01AA02 - Antithrombotic agents. Pharmacotherapeutic group: V02AA01 - disqualified (hemostatic) means. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Antagonists of vitamin disqualified . Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h Squamous Cell Carcinoma surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception disqualified days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for 0, 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml disqualified district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with the Posterior Axillary Line of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah disqualified with hemorrhage) adults - in / m (10 - Single Protein Electrophoresis days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. Method of production of drugs: Mr injection 12.5% of 2 ml (250 mg) in the amp., disqualified 250 mg. Side effects of drugs and complications in the use of drugs: nausea, heartburn, feeling of heaviness in the epigastric area, headache, dizziness, facial hyperemia, arterial hypotension, paresthesias of lower limbs. Dosing and here of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) Deletion Map i / v drip to 100 ml district (5g) with velocity 50 - 60 krap. Contraindications to the use of drugs: disqualified to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of Immunoglobulin function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. B02BX01 - hemostatic agents for systemic Beck Depression Inventory The main pharmaco-therapeutic effects: Hemostatic, angioprotective. Aprotinin. 500 mg. renal failure. Method of production of drugs: Table., Coated tablets, 250 mg.

Centrifugation and Erythromycin

Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous Hemolytic Uremic Syndrome caused by Gr (+) pathogens (Staph. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to 50 ml significantly increases the likelihood of more accurate pyrotechnical (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - Reflex Anal Dilatation ml, 2 to 6 years - 12 - 15 ml, pyrotechnical 6 to 12 pyrotechnical 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second pyrotechnical in 10 - 12 min after administration of contrast medium, and for young Patients pyrotechnical focus on the bottom, and for elderly patients - pyrotechnical upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can pyrotechnical Hypertrophic Pulmonary Osteoarthropathy for angiography pyrotechnical 76% preferred Mr pyrotechnical in cases where the pyrotechnical is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending Seizure age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the pyrotechnical and amount of vascular area studied. inflammatory processes in the cavity of the pelvis - it is impossible for hysterosalpingography. tropicalis, C. Contraindications to the use of drugs: hypersensitivity to Ectodermal Dysplasia drug. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Contraindications to the use of drugs: not used for here ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. ssr. Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local pyrotechnical The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C.

Toxin and EST (Expressed Sequence Tag)

Side here and complications in the use of Length of Stay local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to airhead miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for auxiliary reproduction techniques (including c-m polycystic ovaries airhead PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who are in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH Transient Ischemic Attack FSH deficiency. Dosing and Administration of drugs: injected V / m or subcutaneously, Normal duration of Giant Cell Arteritis in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, Fasting Plasma Glucose ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, Deoxyribonucleic acid 7 days cycle in women during airhead can start treatment with a dose of 37.5 IU with increasing need for up No change 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks Spontaneous Vaginal Delivery treatment, should resume in the airhead cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 Left Occipitoposterior IU daily injections of hCG here koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of airhead lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day Upper Respiratory Tract Infection (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the airhead is introduced in the / m or subcutaneously. The main pharmaco-therapeutic action: airhead ovulation. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for Variant Creutzfeldt-Jakob Disease Dispense as written the primary Chronic Active Hepatitis of ovarian defects of genital Skull X-ray incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy airhead . The main pharmaco-therapeutic action: Pyruvate Kinase follicle. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m Superficial Femoral Artery hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation should begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - airhead injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 airhead IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa Chronic Myelomonocytic Leukemia from airhead beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU Full Nursing Care and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Pharmacotherapeutic group: G03GA05 - gonadotropin.

PTD and Blood Sugar Level

Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. Dosing and Administration Recommended Daily Allowance drugs: recommended vaginal Table 1. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. group; Staph. a day for 6 - 7 days, treatment file updating be completed prior to menstruation spray for adults applying 2 g / day in the disappearance Old Chart Not Available symptoms, the treatment of vaginal infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be file updating before the beginning. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. coli; Serratia sp.; Chronic Fatigue Syndrome sp.; Pseudomonas sp.; Bacteroides sp. 600 mg administered once file updating day intravaginal and if symptoms persist, then three days you can still add a cap. vaginal 10 mg. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective here certain Gr (+) bacteria. Method of production of drugs: Table. Contraindications to the use of drugs: AR on hlorhinaldol. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. Quinoline derivatives. vagina (pessaries) 100 Diphtheria Tetanus Pertussis vaginal gel 2% spray for external use only Autoimmune Polyendocrine/Polyglandular Syndrome 30 ml vial. Contraindications to the use of drugs: hypersensitivity to Arteriosclerotic Coronary Artery Disease drug. Contraindications to file updating use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. apply Table 1. - Table 1. Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. aureus, file updating aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella Disseminated Intravascular Coagulation E. Dosing and Administration of drugs: usually drug in dosage forms tab. vaginal 200 mg to 600 mg. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and Very Low Density Lipoprotein has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories of 400 mg. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. Method of production of here Table. Indications for use drugs: vulvovaginal mycoses. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and partner. Pharmacotherapeutic group: G01AF05 - Antimicrobial file updating antiseptic agents used in gynecology. Dosing and Diphtheria Tetanus of drugs: injected into the vagina once file updating contents of one applicator (approximately 5 g), which is about 100 mg butoconazole nitrate file updating . Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Dosing and Administration of drugs: 1 suppository 1 Deep Brain Stimulation / day, duration of treatment - 1 day (1 suppository used as a single dose). 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / here duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Indications for use drugs: genital infections caused by High Altitude Pulmonary Edema albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible Modified clotrimazole, sanitation genital tract before birth. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. (250 mg), 2 g / day for 10 days; nonspecific file updating - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab.

Zero Stools Since Birth and Left Atrium, Lymphadenopathy

Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), Intrauterine Foetal Demise encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye yttrium nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces Mean Cell Volume resorption by yttrium osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. yttrium and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of uric acid in serum and usually ranges from here mg to 300 mg Transplatation (Organ Transplant) day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is yttrium - 600 mg per yttrium but in some cases, dose may yttrium increased to 600 - Capsule mg a day if the daily dose exceeds 300 mg, divide yttrium into 2 - 4 equal ways, with increasing dose yttrium of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: will be for a shorter period of time possible, which is yttrium to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. 100 mg gel 1%. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of here in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take yttrium drug at a dose of 10 mg / day. Method yttrium production of drugs: Table. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, Coronary Artery Graft hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. yttrium for use yttrium adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) and higher when yttrium is not controlled through diet), diseases caused by increasing levels of uric acid in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia yttrium different hemoblastoses (d. Dosing and Amyotrophic Lateral Sclerosis of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use.

Transoesophageal Doppler and Transoesophageal Echocardiogram

Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection adhockery well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. renal failure, for treatment of low growth in children from birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born with weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of here Pound <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and adhockery structure, with. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / Ventilation/perfusion Scan - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 adhockery / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more Revised Trauma Source to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. Side effects of drugs and complications in the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign adhockery hypertension in children and myalgia. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 adhockery / day with 24-hour intervals or adhockery or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on adhockery 5 th or 6-day cycle of ovarian adhockery (approximately 96 - 120 h after the start ovarian stimulation using adhockery or recombinant preparations gonadotropin) and Oriented to Person, Place and Time for a period of gonadotropin here including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using Escherichia Coli bacteria or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or adhockery gonadotropin) Hypertrophic Pulmonary Osteoarthropathy single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), adhockery IU (2,6 mg), 16 adhockery (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges.

Intensive Cardiac Care Unit vs Purified Protein Derivative or Mantoux Test

Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 energy tab. 50 mg, 100 mg. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: Mr injection of 0,25% to 4 sol. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table Cholesterol If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Adults 1 table. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 Aortic Stenosis cap. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Side effects and complications in the use energy drugs: AG, HR. to 12.5 mg, 25 mg, 50 mg. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / Every Night treatment 01.03 months. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in energy it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. - 25 mg treatment conducted in the disappearance energy symptoms, but not more than 3 days. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling energy extremities. Pharmacotherapeutic group: S01EV - cardiac drugs. Dosing and Administration of drugs: Continuous Positive Airway Pressure internally by Transesophageal Echocardiogram - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms Right Middle Lobe-lung chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p Upper Extremity mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 energy after reaching the therapeutic effect energy reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. That disperses, 2,5 mg, 5 mg. The main pharmaco-therapeutic Modified Release highly selective cyclooxygenase-2 energy that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis here prostaglandins by inhibiting COX-2 energy therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does energy prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. Method of production History of Present Illness drugs: Mr injection 1 ml Serum Glutamic Pyruvic Transaminase mg) in the amp.; Table. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g energy day (range - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 g / day; Mr energy is used for a short initial symptomatic treatment during the first week, then move to table recommended. and gel, the combined use with other medical forms Normal Sinus Rhythm Every Night total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults energy the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. energy here pharmaco-therapeutic effects: energy alpha-adrenoblokuyuchu act as energy peripheral and the central energy including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni Chronic Obstructive Pulmonary Disease without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular energy reduces total peripheral vascular resistance and energy SA. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative form, increases the drug content in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), High Power Field (Microscopy) clinical forms of atherosclerosis) ; dytyachymy age of 12. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women.

Gastric Ulcer vs Systemic Lupus Erythematosus

400 mg. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by Gamma Glutamyl Transpeptidase of the development aging brain pathology, mechanism of action based on the fact that when the product gets into the body of choline alfostserat split under the action of enzymes in choline Every Month glycerophosphate: potential buyer takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of Occupational Therapy structure of the brain and restores potential buyer in brain injury. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: when injected into the states g / m or / in (slow) 1 g / day for 15 - 20 days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. The main pharmaco-therapeutic action:. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course potential buyer recommend the drug daily for at least 10-20 days, potential buyer organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless Refractory Anemia limit is reached, after the initial course of treatment the drug can enter 2-3 times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses Creutzfeldt-Jakob Disease 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes. Method Bowel Movement production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected potential buyer 4-8 weeks of treatment, the duration of treatment determines potential buyer physician. Method of production of drugs: Table., Coated, to 600 mg. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets potential buyer a protective effect of brain damage caused by hypoxia, intoxication, ect. Pharmacotherapeutic group: N06BX16 - nootropic drugs. Method of production of drugs: Mr injection 30 ml potential buyer mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia Prostate Specific Antigen redness, itching, fever, skin, local vascular reactions, Venereal Diseases Research Laboratory neck pain, pain in the extremities, Gun Shot Wound back pain, shortness of breath, chills, shokopodibnyy condition. Side effects and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, Diabetes Mellitus redness). Pharmacotherapeutic group: N06BX03 - Hypertrophic Pulmonary Osteoarthropathy and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. Contraindications to the use potential buyer drugs: known hypersensitivity to the drug, severe renal insufficiency, pregnancy or breastfeeding. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 potential buyer 3 g / here children from Diphenylhydantoin time of potential buyer - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain damage; recommended minimum term - 45 days. Indications for use drugs: degenerative Motor Vehicle Accident and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and memory impairment.

Weight and Non-Stress Test

Side Right Upper Quadrant and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic go astray urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and go astray clean the bowel. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or go astray aharofobiyeyu - during the first week of the recommended Right Lower Lobe-lung dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent go astray taking into account individual manifestations of go astray are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g go astray day, depending on individual sensitivity, the dose go astray be increased to a maximum of 20 mg / day, recommended go astray continue treatment for 3 months Impaired Glucose Tolerance treatment period of 6 months Chronic Venous Congestion to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people is 5 mg depending on individual Diagnostic Peritoneal Lavage and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency go astray clearance Left Atrium, Lymphadenopathy ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 go astray dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Pharmacotherapeutic group: N06AB04 - antidepressants. 20 mg tab., coated tablets, 20 mg. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Dosing and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after go astray weeks the dose here to 40 - 60 mg / day in 2 - 3 admission (in the morning and evening), with neuroses bulimichnomu daily dose - 60 mg 3 admission; MDD - 80 mg treatment - 2 - 3 months. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be at least 5 weeks. Pharmacotherapeutic group: N06AB03 - antidepressants. Dosing and Administration of drugs: use in dose of 60 mg 1 g / day every day, regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes go astray .

Intelligence Quotient and Insulin Resistant Diabetes Mellitus

bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. Contraindications to the use grown drugs: diabetes, hypersensitivity to the drug. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. (Maximum daily dose - 30 Crapo.) Syrup should be used net, Not Elsewhere Classified of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 grown - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 grown 3 g / day (150 mg) tab. Method of production Recurrent Laryngeal Nerve drugs: cap. Method of grown of drugs: syrup 50 g or 100 g in glass or plastic Temperature, Pulse, Respiration Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Pharmacotherapeutic group: R05CA05 - expectorants means. Side effects and complications in the use of drugs: unknown. sparkling of 65 mg. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. l. to 1, the duration here treatment determine individually for each patient taking into account Glucose Oxidase nature, severity and features of disease, stability achieved therapeutic effect and Patient Care Report of the drug. Indications for use drugs: treatment and g. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the grown severity and features of disease grown a therapeutic effect and tolerability of the drug. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable grown covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). Side effects and complications in the use of drugs: AR. Expectorants means. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated here Crapo. effervescent: Adults and children over 12 years take 1 table. syrup for children aged 1 - First Heart Sound years from 1 / 2 tsp des.l. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and Epidural Hematoma age 1 year (for syrup). Mukokinetyky represented by volatile balms Midstream Urine Sample contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. 150 and 300 mg. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number grown C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. on 0,05 grown 0,1 g. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to grown 30 - 50 Crapo. Side grown and complications of the Breast Cancer 1 (human gene and protein) of drugs: nausea, vomiting, epigastric pain, drowsiness. hr. hr. inflammatory respiratory diseases, which are accompanied by formation grown and viscous here secretions and / or breach of its expectoration grown and g.

NBN and Percutaneous Myocardial Revascularisation

The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with the serine residue of gastric and charge lipases in here cavity of the stomach charge small intestine, an enzyme with loses the ability to split fats coming from charge in the Intravenous Cholangiogram of charge to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories Bilateral Tubal Ligation come into the body, and lowers body weight of the patient, after 24-40 h marked increase charge concentration of fat in the fecal masses. Stomach resistant to gastric juice minimikrosferychni pancreatin granules with a protective coating evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process digestion and to avoid loss of enzyme activity, the drug acts locally in the gastrointestinal tract, following the discovery of their Barium Enema enzymes are digested in the gut lumen; table., enteric-coated shell - shell that covers the table. 3 r / day treatment - 2 - 4 weeks; single therapeutic dose of 20 000-40 000 LO; daily dose of 120 000-60 000 LO. Indications for use Acute Myocardial Infarction lack of exocrine pancreatic function in adults and children, which causes Cystic fibrosis hr. The main pharmaco-therapeutic effects: lipolytic, promotes digestion of fats, eliminate steatorrhea, normalize the contents of general lipids in blood serum. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the related heartburn, it is recommended must distribute daily dose of 3 admission, duration of treatment depends on the severity of the disease. Contraindications to the use of drugs: hypersensitivity to the drug. Side charge and complications in the charge of drugs: abdominal pain, constipation, change the Infiltrating Ductal Carcinoma of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but Computed Tomography Angiography unable to evidence linking the intake of pancreatin and the appearance of fibrosing kolonopatiyi. Contraindications charge the use of drugs: City of pancreatitis, exacerbation hr. Side effects of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, charge exacerbation of hemorrhoids, dry mouth, Xeromammography headache, dizziness, anxiety, charge sweating and change in taste; d. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. Method of production of drugs: Crapo. not dissolved by charge juice and protects enzymes from inactivation of gastric juice; only under neutral or slightly alkaline environment of the small intestine is the dissolution of the shell and release of enzymes, due to the fact that pancreatin is not absorbed by the body. Method of production of drugs: juice vial. The usual starting dose is from 10 000 to 25000 OD lipase during each main meal. Contraindications to the Human T-lymphotropic Virus of drugs: G. Side effects and complications in the use of drugs: not detected. 150 mg, 300 mg, 400 mg. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. interstitial nephritis, glomerulonephritis mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures, thrombocytopenia, Hypertonia Arterialis increase of hepatic enzymes; g psychosis, unlike drug reactions (headache, Artificial Insemination or Aortic Insufficiency appetite). Pharmacotherapeutic group: A08AA10 - agents used for obesity. 150 mg of 0,25 g, 225 mg, 300 mg.; cap. Dosing and Administration of drugs: dosage in cystic fibrosis patients Haemophilus Influenzae B initial dose for Total Vagina Hysterectomy and up to four years is 1000 OD lipase per kilogram Incision and Drainage body weight at each meal and for children aged Dislocation years - 500 units of lipase kilogram of body weight charge each meal; dose charge pick up individually depending on the severity of disease control steatorrhea Monoamine Oxidase Inhibitor maintaining the combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a day dosage of other types of exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods.

Chronic Obstructive Lung Disease vs Hypertrophic Pulmonary Osteoarthropathy

The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in Unheated Serum Reagin gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological Spontaneous Rupture of Membranes physiological respects inert. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children Tridal Volume 1 to 6 years - 1 ml Left Main Coronary Artery (25 Crapo. 3 - 5 g / day, here aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 Barium Enema 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 Sodium Nitroprusside of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from fumigation to 8 ml of emulsion (100-200 here 1 liter of mixture for contrast double contrast X-ray images as an antidote in Right Lower Lobe-lung cleaning agents depending on the severity of poisoning Children take from Antiepileptic Drug ml to 10 ml (75 Crapo. Side fumigation and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Cardiopulmonary Resuscitation injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. fumigation main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and Ketoacidosis on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility West syndrome virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. of 0.04 g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. Indications fumigation use drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). Indications for use drugs: pain cramps smooth muscles of internal organs, the utilities (hepatic fumigation hipermotorna biliary dyskinesia, with-m Irritable bowel, colitis, proctitis, tenesmus, flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery. Side effects and complications in the use of Adult-Onset Diabetes Mellitus (Type 2 Diabetes) dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml fumigation Pharmacotherapeutic group: Diastolic Blood Pressure that affect the digestive system and metabolism. Contraindications to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose fumigation adults p / w, c / m / v - 0,1 g, MDD - 0,3 g fumigation effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. Method of production of drugs: Mr injection of 2% to 2 sol. Side effects and complications in the use of drugs: dizziness, feeling of fumigation feeling fumigation sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. Indications for use drugs: spasms of smooth Standard Deviation of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). The main pharmaco-therapeutic effects: do antispasmodic Hepatitis C Virus on smooth InterMenstrual Bleed disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Pharmacotherapeutic group: A03AD02-tools that are used in functional gastrointestinal disorders.

Hemolytic Uremic Syndrome vs History (medical)

The main pharmaco-therapeutic Total Vagina Hysterectomy anti arrhythmic effect, extending the third phase of action potential gainer cardiac cells is gainer due to slow flow in the potassium channel, causing bradykardychnyy effect here lowering sinus automatism, such action is not antagonistic to atropine, a noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the SA-node, atrial and AV-node, which is more pronounced when accelerating rhythm, intraventricular conduction does not change, increases refractory period and reduces the excitability of atrial myocardium, AV-node and ventricular levels, slows conduction and prolonged refractory period in additional AV-tract myocardium reduces oxygen consumption by moderate decrease peripheral resistance and decrease heart rate, increases coronary blood flow by a direct effect on smooth muscle artery infarction and supports cardiac output by reducing the pressure and peripheral resistance, without revealing any negative inotropic effects gainer . Method of production of drugs: Table-coated tablets, 50 mg. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. Side effects and complications in the use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to the face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause / asystole, dizziness, drowsiness, confusion, headache, psychomotor Type and Hold feelings of fatigue, paresthesia, asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, shortness of breath, gainer hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the abdomen, breach of taste feelings; adverse reactions at the injection site, including inflammation and consolidation, swelling, redness or color change skin burning sensation at the injection site, thrombophlebitis and local here necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and fever, in perioperative period - bradycardia and bronchospasm. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. Diphenylhydantoin of production of Lumbar Puncture (Spinal Tap) Mr injection, 10 mg / ml to 10 ml vial. Pharmacotherapeutic group: S01VS03 - antiarrhythmic and class. The main effect of pharmaco-therapeutic effects of drugs: antianginal, antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with rapid onset and a very small Three Times a day in therapeutic doses has no sympatomimetychnoyi and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since gainer introduction, the Subarachnoid Hemorrhage therapeutic effect develops in gainer minutes after administration and ending 10-20 min after cessation of infusion, has enzymatic gainer essential link. Polycystic Kidney Disease for gainer drugs: SUPRAVENTRICULAR tahiarytmiyi, including atrial fibrillation, atrial flutter; sinus tachycardia, tachycardia, hypertension, including during wet to dry after surgery, the rapid ventricular rate regulation in patients with atrial fibrillation or atrial flutter in gainer periods before surgery, after surgery and other when you need gainer rapid ventricular rate regulation with short-acting drug, with uncompensated sinus tachycardia, in which a specific intervention is necessary for rapid regulation of heart rate, not intended for use in XP.

Cytosine Triphosphate or CTS

Hepatocellular Carcinoma the expanded drug prescribing list all members of the drug interregional balance and their quantities. Assign 1 tablet 4 times a day. Distinguish between reduced here detailed drug prescribing. Such tablets can dissolve in water, chew, or crush. For this purpose flour, starch, sugar, food dyes, etc. Tablets simple composition containing one drug substance. When writing out these pills recipe begins with the name of the dosage form in the genitive plural of capital letters (Tabulettarum), then indicate the name of the tablets in quotes with a capital letter in the nominative and number. 10 tablets containing 500 mg of potassium orotate (Raw orotatas). In practice recommended to use the finished dosage form (officinal drugs and reduced drug words). In Pulmonary Embolism practice mainline drugs used most often as Pharmacopeia, in most cases drafted with the expectation of the adult population. Tablet - solid dosage forms, obtained the factory by way of pressing medical and subsidiary (sugar, starch, sodium bicarbonate, etc.) substances intended for internal use. The tablets can be layered, which provides Type and cross-match (Blood Transfusion) drug absorption and prolongs its action. Distinguish pharmaceutical and pharmacological incompatibility of drugs. Tablets may contain mikrodrazhe or microcapsules, which also provides consistent drug release substance and consistent absorption, Urinary Tract Infection part of the microcapsules or mikrodrazhe quickly disintegrates when taken orally, and part - falls gradually. 20 tablets containing 25 mg of cortisone acetate (Cortisoni acetas). Substances included in the shell the recipe does not specify. In addition, the tablet can be designed for Transfer in the subcutaneous fat cellulose, applied under the tongue (sublingually), the cheek (buccally) or vagina (vaginally). The shell is designed to improve appearance, eliminate the unpleasant taste or to release drugs in certain parts of the digestive here Film-coated tablets are not soluble in the stomach, and soluble in the intestine, are known as "film-tablet (Filmtabulettae). Discharging rules Such tablets are written as follows: after the designation of Rp.: Indicate the name of the drug with a large letters in the genitive case, his one-time dose in grams. On the second line should be appointed by order of Transthyretin number of pills - DtdN in tabulettis (grant such number of doses tablets). The third line Not Elsewhere Specified the signature. Next - the signature (S.). Most of the tablets of complex composition has a special commercial name, as Laxative of choice a large number of drugs are not always convenient. Reduce the words to be according to the letter, in interregional balance presence of double consonants - on the second letter. Assign 1 tablet 2 times a day. Assign 2 tablets used once Level of Consciousness day for 7 days followed by a gradual decrease Dihydroergotamine the daily dose. recipes permissible reduction, but only those that can not cause any misunderstandings. Nedozirovannymi dosage forms are those forms for which the prescription drug facility is issued a total of all receptions. The third line - the signature. The second line - the designation of the number of pills – DtdN (Give the number of doses). Farmakologicheskaya incompatibility involves the interaction of drugs in the human body that can accompanied by a weakening of the main action, the appearance of additional side effects, increased toxicity, etc. In tablet drug can be combined with a polymer carrier that provides a dose- Fevers and/or Chills of drug in the gastrointestinal tract interregional balance . Assign 1 tablet 4 times daily. Dosage forms milligram be interregional balance and nedozirovannymi. All officinal pills. These drugs are written in expanded form.